PATENT CLAIM ANALYSIS

Application Number: 16159343
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "455000"]

Abstract:
A synergistic combination of Urolithin A (3,8-dihydroxy-dibenzo-alpha-pyrone) and Urolithin B (3-hydroxy-dibenzo-alpha-pyrone) is provided in a particular effective ratio, optionally in a nutraceutical or pharmaceutical composition. The composition is for use in treating cognitive deficits, including increasing cognitive function or cognitive capacity (nootropic activity). The composition is for use in treating or preventing a dementia-related disorder in a human subject, such as anxiety or Alzheimer's disease, and for inhibition of acetylcholinesterase (AChE).

Claim (Index 11):
The pharmaceutical composition of  claim 10 , wherein the composition is administered in a daily dose of from about 1.5 mg/kg to about 8.0 mg/kg.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15218790', '14656096', '13336841', '13574886', '14469366']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.734135227348513
- 35 USC 102 Novelty (BERT): 0.5294235322504013
- Combined Prediction Score: 0.7136640578387019
- Mean Citation Score: 224.491908
- Max Citation Score: 248.71251
- Similarity Product: 126.8359655176878

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test